Monsanto revises: Bayer stock rises

The company achieved an important success in court, the operation seems to be attractive to investors and investors again. The process affected by the company subsidiary Monsanto is under revision. It is about a glyphosate-containing weedkiller and its presumed carcinogenic effect. The San Francisco judge issued an application submitted by Monsanto. This provides that there is a renegotiation of the penalties imposed. They amount to $ 250 million. Experts believe that the amount is now significantly lower, resulting in financial relief for the company.